Home › Funds › Spruce Street Capital LP › ERAS

Spruce Street Capital LP position in ERAS

ERASCA INC · Health Care

Spruce Street Capital LP reported holding 422,543 shares of ERAS (ERASCA INC) in its Q3 2026 13F filing — a position valued at US$6.2M, representing 0.98% of its reported portfolio and ranking #25 among its reported holdings. Spruce Street Capital LP has disclosed ERAS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)422.54K sh
Reported value held$6.19M
Portfolio Weight0.98%
First reportedQ4 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Spruce Street Capital LP's ERAS position evolved

Spruce Street Capital LP first disclosed a stake in ERAS in Q4 2025 at 3,889,632 shares (US$14.5M). Across 4 filings, Spruce Street Capital LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 422,543 shares valued at US$6.2M. Notable position changes include a 89% trim in Q1 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 3.89M $14.47M New
Q1 2026 422.54K $6.84M Reduce
Q2 2026 422.54K $7.74M Hold
Q3 2026 422.54K $6.19M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ERAS and 13F data

ERAS (ERASCA INC) is a Health Care company. 74 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$328.8M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ERAS

All ERAS fund holders →

FAQ

How long has Spruce Street Capital LP held ERAS?

Spruce Street Capital LP has disclosed ERAS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Spruce Street Capital LP's current position in ERAS?

As of Q3 2026, Spruce Street Capital LP holds 422.54K shares of ERAS (ERASCA INC), valued at $6.19M, representing 0.98% of its reported portfolio and ranking #25.

Has Spruce Street Capital LP been buying or selling ERAS?

In the latest 13F filing (Q3 2026), Spruce Street Capital LP held unchanged its position in ERAS.

Which other funds hold ERAS?

Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 74 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.